Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO
Standard
Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO : Insights from the MeVO-FRONTIERS International Survey. / Kashani, Nima; Cimflova, Petra; Ospel, Johanna M; Kappelhof, Manon; Singh, Nishita; McDonough, Rosalie V; Almekhlafi, Mohammed A; Chen, Michael; Sakai, Nobuyuki; Fiehler, Jens; Ahmed, Uzair; Peeling, Lissa; Kelly, Michael; Goyal, Mayank.
In: CLIN NEURORADIOL, Vol. 33, No. 1, 03.2023, p. 155-160.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO
T2 - Insights from the MeVO-FRONTIERS International Survey
AU - Kashani, Nima
AU - Cimflova, Petra
AU - Ospel, Johanna M
AU - Kappelhof, Manon
AU - Singh, Nishita
AU - McDonough, Rosalie V
AU - Almekhlafi, Mohammed A
AU - Chen, Michael
AU - Sakai, Nobuyuki
AU - Fiehler, Jens
AU - Ahmed, Uzair
AU - Peeling, Lissa
AU - Kelly, Michael
AU - Goyal, Mayank
N1 - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2023/3
Y1 - 2023/3
N2 - BACKGROUND: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.METHODS: We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.RESULTS: A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was "awaiting better tools" (9/28 responses, 32.1%), while "awaiting better evidence" (8/26 responses, 30.8%), and the need for improved "funding" (7/26 responses, 26.9%) were important barriers in Europe.CONCLUSION: The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.
AB - BACKGROUND: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.METHODS: We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.RESULTS: A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was "awaiting better tools" (9/28 responses, 32.1%), while "awaiting better evidence" (8/26 responses, 30.8%), and the need for improved "funding" (7/26 responses, 26.9%) were important barriers in Europe.CONCLUSION: The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.
U2 - 10.1007/s00062-022-01196-5
DO - 10.1007/s00062-022-01196-5
M3 - SCORING: Journal article
C2 - 35854101
VL - 33
SP - 155
EP - 160
JO - CLIN NEURORADIOL
JF - CLIN NEURORADIOL
SN - 1869-1439
IS - 1
ER -